difference in cost sequential testing nt

In that event, the patient is typically offered counseling and diagnostic testing. If the result from part 1 indicates a risk for Down syndrome that is higher than the screen cutoff, the screen is completed, and a report is issued. The results of the ultrasound measurement and blood work, along with the maternal age and demographic information, are used to calculate trisomy 21 (Down syndrome) and trisomy 18 risk estimates. Along with the NT measurement, a maternal serum specimen is collected to measure pregnancy-associated plasma protein A (PAPP-A). Therefore, NT data is accepted only from NT-certified sonographers. The ultrasound measurement, referred to as the NT measurement, is difficult to perform accurately.

This test involves an ultrasound and a blood draw. Sequential screening combines biochemical and ultrasound markers (nuchal translucency: NT) measured in both trimesters of the pregnancy. Sequential screening is a type of cross-trimester screening that has an improved detection rate as compared to either first- or second-trimester screening. Various options for maternal serum screening are available and include: first trimester, second trimester, and cross-trimester. Maternal serum screening is used to identify pregnancies that may have an increased risk for certain birth defects, such as trisomy 21 (Down syndrome), neural tube defects (NTD) and trisomy 18.

Difference in cost sequential testing nt